{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:24Z","timestamp":1760189124466},"reference-count":37,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1903,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1540-8191.1995.tb01231.x","type":"journal-article","created":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T08:31:41Z","timestamp":1276677101000},"page":"133-139","source":"Crossref","is-referenced-by-count":15,"title":["Etiology and Management of Chronic Valve Disease in Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus"],"prefix":"10.1155","volume":"10","author":[{"given":"David M.","family":"Shahian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif B.","family":"Labib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea B.","family":"Schneebaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2010,6,16]]},"reference":[{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0002-8703(93)90124-R","article-title":"A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin negative systemic lupus erythematosus","volume":"125","author":"Gleason","year":"1993","journal-title":"Am Heart J"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM198809293191302","article-title":"Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus","volume":"319","author":"Galve","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(75)90575-6","article-title":"The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients","volume":"58","author":"Bulkley","year":"1975","journal-title":"Am J Med"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(75)90331-9","article-title":"Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement","volume":"59","author":"Paget","year":"1975","journal-title":"Am J Med"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0735-1097(91)90749-Y","article-title":"Cardiac involvement in patients with primary antiphospholipid syndrome","volume":"18","author":"Brenner","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.82.2.369","article-title":"Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies","volume":"82","author":"Nihoyannopoulos","year":"1990","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0002-9149(92)90735-H","article-title":"Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events","volume":"70","author":"Barbut","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0140-6736(90)91373-I","article-title":"Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus","volume":"335","author":"Khamashta","year":"1990","journal-title":"Lancet"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB9|cit9","first-page":"597","article-title":"Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus","volume":"15","author":"Ford","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-9149(75)90018-1","article-title":"Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease","volume":"35","author":"Bulkley","year":"1975","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/ard.47.11.947","article-title":"Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks","volume":"47","author":"Asherson","year":"1988","journal-title":"Ann Rheum Diseases"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB12|cit12","first-page":"584","article-title":"Mitral regurgitation due to lupus endocarditis treated with valve replacement","volume":"129","author":"Brennan","year":"1983","journal-title":"Can Med Assoc J"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archinte.1924.00110300044002","article-title":"A hitherto undescribed form of valvular and mural endocarditis","volume":"33","author":"Libman","year":"1924","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.84.2.920","article-title":"Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist","volume":"84","author":"Asherson","year":"1991","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.7326\/0003-4819-116-12-974","article-title":"Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome","volume":"116","author":"Kattwinkel","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0049-0172(90)90021-7","article-title":"Antiphospholipid antibody syndrome: Immunologic and clinical aspects","volume":"20","author":"Sammaritano","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u201cprimary\u201d antiphospholipid syndrome: Major clinical and serological features","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0002-8703(92)90420-Z","article-title":"Cardiac manifestations of the antiphospholipid syndrome","volume":"124","author":"Kaplan","year":"1992","journal-title":"Am Heart J"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.1992.03490110089036","article-title":"Antiphospholipid antibody syndrome","volume":"268","author":"Lockshin","year":"1992","journal-title":"JAMA"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00858647","article-title":"The \u201cantiphospholipid syndrome\u201d and the \u201clupus anticoagulant.\u201d","volume":"4","author":"Cameron","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0002-9343(89)90337-9","article-title":"Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome","volume":"86","author":"Chartash","year":"1989","journal-title":"Am J Med"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB22|cit22","first-page":"350","article-title":"Thrombotic endocarditis and lupus anticoagulant: A pathogenetic possibility for idiopathic \u201crheumatic type\u201d valvular heart disease","volume":"113","author":"Ford","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB23|cit23","first-page":"349","article-title":"Lupus anticoagulant: Revival of an old phenomenon","volume":"3","author":"Derksen","year":"1985","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB24|cit24","first-page":"839","article-title":"Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies","volume":"14","author":"Anderson","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB25|cit25","first-page":"539","article-title":"Cerebral and valve lesions in SLE: Association with antiphospholipid antibodies","volume":"15","author":"Asherson","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB26|cit26","first-page":"795","article-title":"IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes","volume":"15","author":"Cronin","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0002-9149(90)90329-Y","article-title":"Cardiac involvement in systemic lupus erythematosus detected by echocardiography","volume":"65","author":"Crozier","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0735-1097(92)90368-W","article-title":"Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies","volume":"20","author":"Roldan","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/bmj.296.6635.1505","article-title":"Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus","volume":"296","author":"Brown","year":"1988","journal-title":"Br Med J"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.CIR.88.2.787","article-title":"Chest pain in a 26-year-old woman with a history of systemic lupus erythematosus and hypertension","volume":"88","author":"Willerson","year":"1993","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/hrt.62.1.61","article-title":"Findings at necropsy in the heart of a patient with anticardiolipin syndrome","volume":"62","author":"Murphy","year":"1989","journal-title":"Br Heart J"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9343(90)90368-N","article-title":"Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus","volume":"89","author":"Leung","year":"1990","journal-title":"Am J Med"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-5223(19)37508-7","article-title":"Cardiac valve replacement in systemic lupus erythematosus","volume":"85","author":"Dajee","year":"1983","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB34|cit34","first-page":"225","article-title":"The expanding spectrum of Libman Sacks endocarditis: The role of antiphospholipid antibodies","volume":"7","author":"Asherson","year":"1989","journal-title":"Clin Exper Rheumatol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB35|cit35","first-page":"1499","article-title":"A possible role for antiphospholipid antibodies in acquired cardiac valve deformity","volume":"17","author":"Ford","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/hrt.41.6.730","article-title":"Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis","volume":"41","author":"Vaughton","year":"1979","journal-title":"Br Heart J"},{"key":"10.1111\/j.1540-8191.1995.tb01231.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","article-title":"Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients","volume":"117","author":"Rosove","year":"1992","journal-title":"Ann Int Med"}],"container-title":["Journal of Cardiac Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8191.1995.tb01231.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1540-8191.1995.tb01231.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T11:50:53Z","timestamp":1673005853000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8191.1995.tb01231.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,16]]},"references-count":37,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1111\/j.1540-8191.1995.tb01231.x","relation":{},"ISSN":["0886-0440","1540-8191"],"issn-type":[{"value":"0886-0440","type":"print"},{"value":"1540-8191","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,16]]}}}